SELLAS Life Sciences (SLS) Return on Capital Employed Growth (3y) (2015 - 2026)
SELLAS Life Sciences (SLS) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | 34,863.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,863.00 |
| Dec 31, 2025 | 47,840.00 |
| Sep 30, 2025 | 19,175.00 |
| Jun 30, 2025 | 20,194.00 |
| Mar 31, 2025 | 16,440.00 |
| Dec 31, 2024 | -14,092.00 |
| Sep 30, 2024 | -27,105.00 |
| Jun 30, 2024 | -40,962.00 |
| Mar 31, 2024 | -403,281.00 |
| Dec 31, 2023 | 66,045.00 |
| Sep 30, 2023 | -228,586.00 |
| Jun 30, 2023 | -16,782.00 |
| Mar 31, 2023 | -21,666.00 |
| Dec 31, 2020 | 5,044.00 |
| Sep 30, 2020 | -15,297.00 |
| Jun 30, 2020 | -16,172.00 |
| Mar 31, 2020 | 40,765.00 |
| Dec 31, 2017 | -4,481.00 |
| Sep 30, 2017 | 7,245.00 |
| Jun 30, 2017 | 5,354.00 |